Monoclonal antibodies against interleukin-22
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 29, 2009
Grant Date -
Feb 24, 2005
app pub date -
Jun 22, 2004
filing date -
Feb 23, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Antibodies and antigen-binding fragments thereof that bind interleukin-22 (IL-22), in particular, human IL-22, and their uses in regulating IL-22-associated immune responses are disclosed. The antibodies disclosed herein are useful in diagnosing, preventing, or treating IL-22-associated immune disorders, e.g., autoimmune disorders (e.g., arthritis).
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully